ArticleVeterinary research communications2025
Protective effect of selenomethionine on spleen and sacculus rotundus injury induced by aflatoxin B1 in reserve male rabbits.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chitosan-selenium alleviates AFB1-induced growth impairment and immunotoxicity in broilers by suppressing splenic oxidative stress, inflammation and apoptosis.Frontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study is to explore the protective effect of selenomethionine (SeMet) against the immunotoxicity caused by aflatoxin B1 (AFB1) in male rabbits. Fifty healthy male rabbits aged 90 days were randomly divided into 5 groups: control group, model group, low dose selenomethionine group (Se-1), middle dose selenomethionine group (Se-2) and high dose selenomethionine group (Se-3). The control group and model group were fed basal diet, and the other three groups were fed SeMet 0.2 mg/kg, 0.4 mg/kg and 0.6 mg/kg respectively. On the 31st day of the experiment, All rabbits in the model group and three treatment groups were fed 0.5 mg/kg AFB1 for 21 days. Detect the levels of immune-related indicators in rabbit plasma. Collect samples, and observe the pathological changes in rabbit spleen and sacculus rotundus using hematoxylin-eosin (HE) staining. Analyze the expression of related proteins in spleen and sacculus rotundus tissues using immunofluorescence and Western blot (WB) analysis. Measure the levels of relevant inflammatory factor mRNA in spleen and sacculus rotundus tissues using qRT-PCR. Use enzyme-linked immunosorbent assay (ELISA) to detect the levels of oxidative stress-related indicators and inflammatory factors in spleen and sacculus rotundus tissues. The results indicate that AFB1 can induce oxidative stress and inflammation by activating the TLR-2/NF-κB signaling pathway, inhibiting the proliferation and differentiation of spleen and bursa cells, disrupting the normal structure of the spleen and sacculus rotundus tissues, and reducing the levels of immune-related indicators in plasma. SeMet pretreatment significantly inhibited the TLR-2/NF-κB signaling pathway, alleviating oxidative stress damage in spleen and sacculus rotundus tissues and reducing the inflammatory response in rabbits.Thus, we demonstrate that SeMet mitigates AFB1-induced immunotoxicity in reserve male rabbits by inhibiting the TLR-2/NF-κB signaling pathway. In addition, in this study, the effect of 0.4 mg/kg SeMet was the most effective. SeMet is a natural and safe drug that can prevent AFB1 poisoning in rabbit feed.
Indexed as
Identifiers
41148392What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.